#news #biotech Merck must do a new trial for faltering $425M COVID-19 drug the U.S. government asked it to buy

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Merck must do a new trial for faltering $425M COVID-19 drug the U.S. government asked it to buy .Merck must do a new trial for faltering $425M COVID-19 drug the U.S. government asked it to buy
badams
Wed, 03/03/2021 – 07:50

from FierceBiotech: Biotech https://ift.tt/3reOJgC